Celgene Corp (CELG) 115.88 $CELG
3 Biotech Stocks I Love
Todd Campbell, The Motley Fool - Motley Fool - 58 mins ago
Source: Flickr user Simon & His Camera . Love is in the air, and that makes it the perfect time to confess my affection for three large-cap biotech stocks that market a slate of highly profitable, market-share leading therapies. Read on to...
BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ABBV: 58.05 (+1.00), CELG: 115.88 (+0.16)
Midday Glance: Biotechnology companies
AP - Fri Feb 13, 12:23PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)
Jim Cramer's Stop Trading: Apache Has Room to Rise, J&J Takes It on the Chin
at The Street - Fri Feb 13, 12:19PM CST
Jim Cramer says independent energy company Apache is one to watch on great production, growth and a Merrill Lynch upgrade.
JNJ: 99.62 (+1.18), PXD: 157.85 (+9.71), APA: 67.05 (+2.47), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Early Glance: Biotechnology companies
AP - Fri Feb 13, 10:05AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
'Mad Money' Lightning Round: Just Say No to Conoco Stock
at The Street - Fri Feb 13, 5:00AM CST
Cramer wants to own FreshPet and prefers Pepsico over Dr Pepper Snapple.
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), CELG: 115.88 (+0.16), PEP: 99.13 (-1.14), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), REGN: 402.40 (+0.66)
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Buy the Best and Leave the Rest
at The Street - Thu Feb 12, 7:12PM CST
Rarely does the market put the winning lottery ticket right in front of you, but today's winners were hiding in plain sight, Cramer says.
WFM: 56.15 (-0.15), MLM: 145.23 (+3.15),
72.91 (-0.81), TSLA: 203.77 (+0.89), FRPT: 16.78 (-0.12), SKX: 66.09 (-0.06), TRIP: 84.81 (+2.41), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), OWW: 11.68 (-0.04), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), WWAV: 38.65 (+0.61), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), EXPE: 89.49 (-0.08), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03)
Final Glance: Biotechnology companies
AP - Thu Feb 12, 5:03PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)
6 Reason Why You Should Reject the McDonald's Mini-Tender Offer
Rich Duprey, The Motley Fool - Motley Fool - Thu Feb 12, 7:23AM CST
Even though the golden arches of McDonald's have been tarnished in recent periods, there's no reason for investors to give up their shares at a discount. McDonald's investors might have been surprised last week to learn someone was offering...
WFM: 56.15 (-0.15), EA: 56.39 (+0.20), MCD: 95.65 (+0.56), CELG: 115.88 (+0.16)
Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), VIA: 69.08 (+1.02), ETP: 60.17 (+0.96), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), KEY: 14.11 (-0.08), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), ETP: 60.17 (+0.96), STI: 41.57 (+0.01), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Celgene Up on Abraxane Getting Positive Recommendation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:59PM CST
Celgene Corporation (CELG) was up 1.7% after the company announced that Abraxane has received a positive recommendation from the Scottish Medicines Consortium.
ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20), LLY: 70.56 (+0.03), CELG: 115.88 (+0.16)
SmarTrend Watching for Potential Rebound in Shares of Celgene After 1.48% Loss
Comtex SmarTrend(R) - Wed Feb 11, 3:41PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $117.28 to a high of $120.73. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $117.49 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 115.88 (+0.16)
Watch for Celgene to Potentially Rebound After Falling 1.48% Yesterday
Comtex SmarTrend(R) - Wed Feb 11, 3:40PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $117.28 to a high of $120.73. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $117.49 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 115.88 (+0.16)
German Researchers Verify Positive, System-Wide Effect Of Pluristem's PLX Cell Therapy
Sharon di Stefano - Seeking Alpha - Wed Feb 11, 3:31PM CST
Pluristem Therapeutics Inc. (NASDAQ: PSTI ), maker of cell therapy for a wide variety of diseases, recently announced 12-month results from Phase I/II studies with its PLX-PAD off-the-shelf treatment for people who had undergone total hip...
PSTI: 2.91 (+0.01), CYTX: 0.47 (unch), STEM: 1.09 (-0.01), ATHX: 2.12 (unch), CUR: 3.41 (+0.13), CELG: 115.88 (+0.16)
Stocks End Mixed: Molina Healthcare Rises Again
at Investor's Business Daily - Wed Feb 11, 3:22PM CST
Stocks ended mixed Wednesday as investors fretted about talks between Greek and European finance ministers about a debt compromise. The Nasdaq edged up 0.3%, while the S&P 500 and the Dow Jones industrial average each dipped a fraction. Volume was...
BIIB: 391.66 (-0.45), MOH: 59.66 (+0.26), CELG: 115.88 (+0.16), RAD: 8.34 (+0.25)
3 Biotech Stocks I Love
Todd Campbell, The Motley Fool - Motley Fool - 58 mins ago
Source: Flickr user Simon & His Camera . Love is in the air, and that makes it the perfect time to confess my affection for three large-cap biotech stocks that market a slate of highly profitable, market-share leading therapies. Read on to...
BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ABBV: 58.05 (+1.00), CELG: 115.88 (+0.16)
Midday Glance: Biotechnology companies
AP - Fri Feb 13, 12:23PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)
Jim Cramer's Stop Trading: Apache Has Room to Rise, J&J Takes It on the Chin
at The Street - Fri Feb 13, 12:19PM CST
Jim Cramer says independent energy company Apache is one to watch on great production, growth and a Merrill Lynch upgrade.
JNJ: 99.62 (+1.18), PXD: 157.85 (+9.71), APA: 67.05 (+2.47), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Early Glance: Biotechnology companies
AP - Fri Feb 13, 10:05AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
'Mad Money' Lightning Round: Just Say No to Conoco Stock
at The Street - Fri Feb 13, 5:00AM CST
Cramer wants to own FreshPet and prefers Pepsico over Dr Pepper Snapple.
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), CELG: 115.88 (+0.16), PEP: 99.13 (-1.14), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), REGN: 402.40 (+0.66)
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Buy the Best and Leave the Rest
at The Street - Thu Feb 12, 7:12PM CST
Rarely does the market put the winning lottery ticket right in front of you, but today's winners were hiding in plain sight, Cramer says.
WFM: 56.15 (-0.15), MLM: 145.23 (+3.15),
72.91 (-0.81), TSLA: 203.77 (+0.89), FRPT: 16.78 (-0.12), SKX: 66.09 (-0.06), TRIP: 84.81 (+2.41), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), OWW: 11.68 (-0.04), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), WWAV: 38.65 (+0.61), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), EXPE: 89.49 (-0.08), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03) Final Glance: Biotechnology companies
AP - Thu Feb 12, 5:03PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)
6 Reason Why You Should Reject the McDonald's Mini-Tender Offer
Rich Duprey, The Motley Fool - Motley Fool - Thu Feb 12, 7:23AM CST
Even though the golden arches of McDonald's have been tarnished in recent periods, there's no reason for investors to give up their shares at a discount. McDonald's investors might have been surprised last week to learn someone was offering...
WFM: 56.15 (-0.15), EA: 56.39 (+0.20), MCD: 95.65 (+0.56), CELG: 115.88 (+0.16)
Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), VIA: 69.08 (+1.02), ETP: 60.17 (+0.96), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), KEY: 14.11 (-0.08), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), ETP: 60.17 (+0.96), STI: 41.57 (+0.01), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Celgene Up on Abraxane Getting Positive Recommendation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:59PM CST
Celgene Corporation (CELG) was up 1.7% after the company announced that Abraxane has received a positive recommendation from the Scottish Medicines Consortium.
ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20), LLY: 70.56 (+0.03), CELG: 115.88 (+0.16)
SmarTrend Watching for Potential Rebound in Shares of Celgene After 1.48% Loss
Comtex SmarTrend(R) - Wed Feb 11, 3:41PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $117.28 to a high of $120.73. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $117.49 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 115.88 (+0.16)
Watch for Celgene to Potentially Rebound After Falling 1.48% Yesterday
Comtex SmarTrend(R) - Wed Feb 11, 3:40PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $117.28 to a high of $120.73. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $117.49 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 115.88 (+0.16)
German Researchers Verify Positive, System-Wide Effect Of Pluristem's PLX Cell Therapy
Sharon di Stefano - Seeking Alpha - Wed Feb 11, 3:31PM CST
Pluristem Therapeutics Inc. (NASDAQ: PSTI ), maker of cell therapy for a wide variety of diseases, recently announced 12-month results from Phase I/II studies with its PLX-PAD off-the-shelf treatment for people who had undergone total hip...
PSTI: 2.91 (+0.01), CYTX: 0.47 (unch), STEM: 1.09 (-0.01), ATHX: 2.12 (unch), CUR: 3.41 (+0.13), CELG: 115.88 (+0.16)
Stocks End Mixed: Molina Healthcare Rises Again
at Investor's Business Daily - Wed Feb 11, 3:22PM CST
Stocks ended mixed Wednesday as investors fretted about talks between Greek and European finance ministers about a debt compromise. The Nasdaq edged up 0.3%, while the S&P 500 and the Dow Jones industrial average each dipped a fraction. Volume was...
BIIB: 391.66 (-0.45), MOH: 59.66 (+0.26), CELG: 115.88 (+0.16), RAD: 8.34 (+0.25)
